Cardiovascular disease who
Cardiovascular disease who
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Cardiovascular diseases: the role of The world health organization (WHO) Cardiovascular diseases (HKK) is worldwide the leading cause of death and are associated with significant socio-economic costs. According to the latest data from the world health organization (WHO) die each year, approximately 17.9 million people to the consequences of cardiovascular disease, nearly 32 % of all deaths worldwide. More than 75% in low — and middle-developed countries. Definition and main forms Heart disease refers to a group of diseases that affect the heart and blood vessels. Among the most important forms: Coronary heart disease (CHD), Stroke (Apoplexy), Heart failure, arrhythmic heart disease, High Blood Pressure (Hypertension), peripheral arterial occlusive disease. Risk factors according to the WHO Definition The WHO has identified a number of modifiable and non-modifiable risk factors: Modifiable Factors: unhealthy diet (high in salt, sugar and fat content), lack of physical activity, Tobacco, excessive consumption of alcohol, Overweight and obesity, increased blood pressure, elevated blood fat levels (dyslipidemia), increased blood sugar level (Diabetes mellitus). Non-modifiable factors: Age Gender (men are up to 50. Age at greater risk), family history. Strategies of the WHO for the prevention The WHO has developed a number of global initiatives for the reduction of cardiovascular diseases. The Central objective of the Global non-communicable diseases action plan 2025 is to reduce premature deaths from non-communicable diseases (including HKK) to 25%. These include measures such as: Introduction of salt-reduction programmes, Ban on industrially produced trans-fatty acids, Increased taxes on sugary drinks and tobacco, The promotion of physical activity in cities and schools, Building health systems for early detection and treatment of hypertension and Diabetes. Conclusion Cardiovascular diseases remain one of the biggest health challenges of the present. The WHO plays a Central role in the coordination of international efforts to combat these diseases. Through evidence-based prevention strategies, global agreements and the support of health systems in developing countries, the burden of heart and circulatory diseases in the world are sustainably reduced.
A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently. Cardiovascular disease who. Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect.
Signs of cardiovascular disease in men
Beet-kvass from high blood pressure
Types of prevention of cardiovascular diseases
http://wellli8s.beget.tech/articles/58844-types-and-causes-of-cardiovascular-diseases.html
https://gpt.lovehiv.ru/articles/4073-blood-pressure-tablets-val-sakor.html
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Sa isang mundo kung saan ang stress at pagmamadali ay nagiging bahagi ng araw-araw na buhay, mas nagiging mahalaga ang pagpapahalaga sa kalusugan ng puso. Ang mataas na presyon ng dugo o hypertension ay nagiging mas karaniwan sa mga tao sa lahat ng edad. Gayunpaman, may iba't ibang paraan at pamamaraan para kontrolin ang presyon at mapabuti ang paggana ng cardiovascular system. Isa sa mga epektibong paraan ay ang Cardio Balance Capsules, isang natatanging solusyon para mapanatili ang kalusugan ng puso at maibalik sa normal ang presyon ng dugo. Tara, alamin natin nang sama-sama kung ano ang mga kapsul na ito at paano ito tamang gamitin.
Val’sakor as a pharmacological Option for the treatment of hypertension: mechanism of action, application and clinical evidence High blood pressure (arterial hypertension) is one of the most common chronic diseases worldwide and a major risk factor for cardiovascular events such as heart attack and stroke. An effective reduction in blood pressure is considered to be a Central component of the prevention of these complications. In this context, the preparation Val’sakor is gaining in importance, belonging to the group of Angiotensin II receptor blocker (ARB). Mechanism of action The active ingredient in the Val’sakor is Valsartan. He acts selectively as a competitive Antagonist at the Angiotensin II type 1 Receptor (AT1‑Receptor). Due to this blockage prevents Valsartan, the vasoconstrictor and aldosterone-secreting effects of Angiotensin II, Which leads to a Relaxation of the blood vessels (vasodilation), a reduction of peripheral vascular resistance and, ultimately, to a drop in blood pressure. In contrast to ACE inhibitors, Valsartan caused no accumulation of Bradykinin, which is why the typical side-effect complex with cough significantly less likely to occur. Pharmacokinetics Valsartan following oral administration is quickly, however, incomplete absolute bioavailability is absorbed (about 25% – 30%). The maximum plasma concentration (C max ) is reached after about 2-4 hours. The elimination half-life is about 6 hours. The drug is mainly eliminated unchanged via the bile. Clinical Application Val’sakor is used for the treatment of essential hypertension in adults. The usual starting dose is 80 mg once daily. If necessary, the dose may be increased after 2 weeks to 160 mg or 320 mg daily. The product, regardless of the meals. In clinical studies (e.g., VALUE‑study), it was shown that Valsartan achieved a comparable reduction in blood pressure as other antihypertensive agents (e.g., amlodipine) and, in addition, a beneficial effect on cardiovascular endpoints has. Side effects and contraindications Among the possible side effects of Val’sakor: Headache, Dizziness, Hypotension, Hyperkalemia (elevated potassium levels), Renal impairment (especially in patients with bilateral renal artery stenosis). Contraindicated the application is: severe liver or bile duct disease, bilateral renal artery stenosis, Pregnancy and breast-feeding, known Hypersensitivity to Valsartan or any of the excipients. Conclusion Val’sakor (Valsartan) is due to its mechanism of action and good tolerability, a valuable Option in the long-term treatment of arterial hypertension. The clinical evidence supports its efficacy in the control of blood pressure and the reduction of cardiovascular risks. An individual dosing and regular Monitoring of renal function and Serum potassium are essential prerequisites for a safe and effective therapy.